258 related articles for article (PubMed ID: 15940362)
1. Interleukin-11 receptor signaling is required for normal bone remodeling.
Sims NA; Jenkins BJ; Nakamura A; Quinn JM; Li R; Gillespie MT; Ernst M; Robb L; Martin TJ
J Bone Miner Res; 2005 Jul; 20(7):1093-102. PubMed ID: 15940362
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
4. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
5. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways.
Syed FA; Mödder UI; Fraser DG; Spelsberg TC; Rosen CJ; Krust A; Chambon P; Jameson JL; Khosla S
J Bone Miner Res; 2005 Nov; 20(11):1992-2001. PubMed ID: 16234973
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
7. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
9. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.
Wu Y; Torchia J; Yao W; Lane NE; Lanier LL; Nakamura MC; Humphrey MB
PLoS One; 2007 Jul; 2(7):e586. PubMed ID: 17611621
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.
Passeri G; Girasole G; Jilka RL; Manolagas SC
Endocrinology; 1993 Aug; 133(2):822-8. PubMed ID: 8393776
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice.
Fujita S; Kikuchi T; Sobue T; Suzuki M; Koide M; Noguchi T
J Periodontol; 2008 Nov; 79(11):2173-81. PubMed ID: 18980527
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of osteoclast activity and bone turnover in different skeletal sites.
Goldberg S; Grynpas MD; Glogauer M
Arch Oral Biol; 2016 Nov; 71():134-143. PubMed ID: 27505033
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
[TBL] [Abstract][Full Text] [Related]
16. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice.
Cuzzocrea S; Mazzon E; Dugo L; Genovese T; Di Paola R; Ruggeri Z; Vegeto E; Caputi AP; Van De Loo FA; Puzzolo D; Maggi A
Endocrinology; 2003 Mar; 144(3):1098-107. PubMed ID: 12586786
[TBL] [Abstract][Full Text] [Related]
19. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
